Does immunoglobulin interfere with the immunogenicity to Pasteur Merieux inactivated hepatitis A vaccine?

Journal of Hepatology

Volumn 26, Issue 1, 1997, Pages 25-30

  Zanetti, Alessandro ^a   Pregliasco, Fabrizio ^a   Andreassi, Aida ^a   Pozzi, Alberto ^a   Viganò, Paolo ^b   Cargnel, Antonietta ^b   Briantais, Philippe ^c   Vidor, Emmanuel ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Pasteur Merieux Serums et Vaccins   (France)

Author keywords

hepatitis A; immunoglobulin; interference; vaccine trial

Indexed keywords

GAMMABULIN; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN; UNCLASSIFIED DRUG; VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FLU LIKE SYNDROME; GLOMERULONEPHRITIS; HEPATITIS A; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RASH;

EID: 0031035278     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80005-0     Document Type: Article

References (27)

1. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelly PW. Frequency of illness associated with hepatitis A virus infection in adults. Am J Epidemiol. 122:1985;226-231.
2. Flehmig B, Heinricy U, Pfisterer M. Immunogenicity of a kiled hepatitis A vaccine in seronegative volunteers. Lancet. i:1989;1039-1041.
3. André FE, Hondt d' E, Delem AD, Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine - rationale and summary of findings. Vaccine. 10:1992;S160-S168.
4. Nalin DR, Kuter BJ, Brown L, Patterson C, Calandra GB, Werzberger A, Shouval D, Ellerbeck EF, Block SL, Bishop RP, Wiens B, Schwartz SW, Lewis JA, Sitrin RD, Provost PJ, Miller WJ, Ryan JL. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J Hepatol. 18:1993;S51-S55.
5. Pellegrini V, Fineschi N, Matteucci G, Marsili I, Nencioni L, Puddu M, Garelick H, Zuckerman AJ. Preparation and immunogenicity of an inactivated hepatitis-A vaccine. Vaccine. 11:1993;383-387.
6. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB, Boslego JW. Protection against hepatitis A by an inactivated vaccine. JAMA. 271:1994;1328-1334.
7. Prikazsy V, Olear V, Cernoch A, Safary A, Andre FE. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol. 44:1994;457-459.
8. Santagostino E, Gringeri A, Rocino A, Zanetti A, De Biasi R, Mannucci PM. Patterns of immunogenicity of an inactivated Hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemostas. 72:1994;508-510.
9. Vandamme P, Thoelen S, Cramm M, Groote de K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol. 44:1994;446-451.
10. Goilav C, Zuckerman J, Lafrenz M, Vidor E, Lauwers S, Ratheau C, Benichou G, Zuckerman AJ. Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study. J Med Virol. 46:1995;287-292.
11. Leentvaarkuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 10:1992;S138-S141.
12. Zaaijer HL, Leentvaarkuijpers A, Rotman H, Lelie PN. hepatitis A antibody titres after infection and immunization - implications for passive and active immunization. J Med Virol. 40:1993;22-27.
13. Wagner G, Lavanchy D, Darioli R, Pecoud A, Brulein V, Safary A, Frei PC. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Vaccine. 11:1993;1027-1032.
14. Green MS, Cohen D, Lerman Y, Sjögren MH, Binn LN, Zur S, Slepon R, Robin G, Hoke CH, Bancroft WH, Safery A, Danon Y, Wiener M. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 168:1993;740-743.
15. Frösner GG, Overby LR, Flehmig B, Gerth HJ, Haas H, Decker RH, Ling CM, Zuckerman AJ, Frösner HR. Serological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol. 1:1997;163-173.
16. Flehmig B, Haage A, Heinricy U, Pfisterer M. Studies with an inactivated hepatitis A vaccine. Zuckerman AJ. Viral Hepatitis and Liver Disease. 1988;100-105 Alan R. Liss, Inc. New York.
17. Garin D, Vidor E, Wallon M, Fanget B, Brasseur P, Delome H, Caron F, Mojon M, Gravey A, Hubert G, Flehmig B, Peyron F. Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults. Vaccine. 13:1995;220-224.
18. Miller WJ, Clark W, Hurni WM, Kuter B, Schofield T, Nalin DR. Sensitive assays for hepatitis A antibodies. J Med Virol. 41:1993;201-204.
19. Gerety RJ, Smallwood LA, Finlayson JS, Tabor E. Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin. Development in Biological Standardization. 54:1983;411-416 Karger, Basel: S.
20. Dal-Ré R, Gil A, Gonzalez A, Lasheras L. Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative trial in adults. J Clin Pharmacol. 35:1995;420-425.
21. Lelie PN, Reesnik HW, Grijm R, de Jong-van Manen ST, Reerink-Brongers EE. Simultaneous passive and active immunisation against hepatitis B: non-interference of hepatitis B immunoglobulin with the anti-HBs response to reduced doses of heat-inactivated hepatitis B vaccine. Hepatology. 6:1986;971-975.
22. Vodopija I, Sureau P, Smerdel S, Lafon M, Baklaic Z, Ljubicic M, Svjetlicic M. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine. 6:1988;283-286.
23. Galletti R, Beauverger P, Wild TF. Passively administered antibody suppresses the induction of measles virus antibodies by vaccine-measles recombinant viruses. Vacine. 13:1995;197-201.
24. Murphy BR, Collins PL, Lawrence L, Zubak J, Chanock RM, Prince GA. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies; partial prevention by topical infection in the respiratory tract with vaccinia virus-RSV recombinants. J Gen Virol. 70:1989;2185-2190.
25. Green MS, Melnick JL, Cohen D, Slepon R, Danon YL. Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988. J Infect Dis. 162:1990;971-974.
26. Schumacher CL, Ertl HCJ, Koprowski H, Dietzschold B. Inhibition of immune response against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine. 10:1992;754-760.
27. Rowley DA, Fitch FW, Stuart FP, Stuard FP, Köhler H, Cosenza H. Specific suppression of immune responses by antibody directed against either antigen or receptors for antigen can suppress immunity specifically. Science. 181:1973;1133-1141.